Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -14.18%3.59B | -16.44%8.66B | -6.98%4.18B | -0.68%10.36B | -2.59%4.49B | 1.70%10.43B | 0.16%4.61B | 8.52%10.26B | 6.18%4.6B | 12.35%9.45B |
| Operating income | -14.18%3.59B | -16.44%8.66B | -6.98%4.18B | -0.68%10.36B | -2.59%4.49B | 1.70%10.43B | 0.16%4.61B | 8.52%10.26B | 6.18%4.6B | 12.35%9.45B |
| Cost of sales | ---- | 16.24%-7.1B | ---- | 1.46%-8.48B | 6.67%-3.65B | -2.58%-8.6B | -3.02%-3.91B | -8.58%-8.38B | -6.49%-3.79B | -14.66%-7.72B |
| Operating expenses | 13.98%-2.89B | 16.24%-7.1B | 7.75%-3.36B | 1.46%-8.48B | 6.67%-3.65B | -2.58%-8.6B | -3.02%-3.91B | -8.58%-8.38B | -6.49%-3.79B | -14.66%-7.72B |
| Gross profit | -15.01%692.94M | -17.34%1.56B | -3.66%815.36M | 2.94%1.89B | 20.00%846.34M | -2.21%1.83B | -13.22%705.29M | 8.23%1.87B | 4.79%812.72M | 3.11%1.73B |
| Selling expenses | 6.75%-26.75M | 23.01%-63.2M | 23.68%-28.68M | -5.82%-82.09M | -22.78%-37.58M | -2.67%-77.58M | 6.01%-30.61M | -29.33%-75.56M | -5.76%-32.57M | 20.13%-58.43M |
| Administrative expenses | 2.01%-223.21M | 11.55%-866.19M | 45.67%-227.8M | -11.50%-979.28M | -20.99%-419.27M | -2.71%-878.27M | 8.40%-346.54M | -15.04%-855.06M | -14.37%-378.32M | 10.18%-743.28M |
| Research and development expenses | 3.89%-141.9M | ---- | ---147.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit from asset sales | 33.72%623.46K | ---- | --466.25K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | 136.57%1.36M | ---- | ---3.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | 136.57%1.36M | ---- | ---3.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 6.69%-94.16M | 38.85%-175.02M | 30.90%-100.9M | -17.44%-286.21M | 16.78%-146.03M | 34.55%-243.71M | 12.63%-175.48M | -39.27%-372.39M | -43.49%-200.86M | -52.24%-267.38M |
| -Other impairment is provision | 6.69%-94.16M | 38.85%-175.02M | 30.90%-100.9M | -17.44%-286.21M | 16.78%-146.03M | 34.55%-243.71M | 12.63%-175.48M | -39.27%-372.39M | -43.49%-200.86M | -52.24%-267.38M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | -12.97%-320.41M | -28.44%-164.4M | -16.57%-283.61M | -7.27%-127.99M | -4.84%-243.3M |
| Special items of operating profit | -34.20%47.95M | -40.78%417.18M | -66.63%72.88M | 45.86%704.42M | -20.35%218.36M | -0.06%482.94M | 22.26%274.16M | 25.59%483.21M | 4.71%224.23M | 0.94%384.75M |
| Operating profit | -35.79%238.88M | -29.86%872.11M | -19.45%372.01M | 56.28%1.24B | 75.99%461.82M | 3.24%795.53M | -11.71%262.42M | -4.14%770.58M | -19.42%297.22M | 6.90%803.85M |
| Financing cost | 8.26%55.3M | 3.02%-282.02M | 134.64%51.08M | ---290.8M | ---147.45M | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | -26.67%37.99M | ---- | 87.96%51.81M | 176.42%28.11M | 1,341.11%27.57M | 6,377.07%10.17M | -805.08%-2.22M | -17.80%157K | -90.25%315K |
| Share of profit from joint venture company | ---- | -58.58%5.59M | ---- | -92.90%13.49M | -4.27%90.88M | -15.73%189.99M | -23.20%94.93M | 158.63%225.45M | 151.59%123.6M | 492.99%87.17M |
| Adjustment items of earning before tax | -129.31%-2.35M | ---- | --8.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -32.31%291.83M | -37.74%633.68M | -0.52%431.11M | 0.47%1.02B | 17.92%433.36M | 1.94%1.01B | -12.70%367.52M | 11.50%993.81M | 0.67%420.97M | 15.77%891.33M |
| Tax | 13.07%-52.44M | 6.74%-100.21M | -83.39%-60.33M | 6.90%-107.45M | 33.48%-32.9M | 17.50%-115.42M | -17.48%-49.45M | -29.25%-139.89M | 31.17%-42.09M | -3.73%-108.24M |
| After-tax profit from continuing operations | -35.44%239.39M | -41.40%533.47M | -7.41%370.79M | 1.41%910.35M | 25.91%400.46M | 5.12%897.68M | -16.05%318.06M | 9.04%853.92M | 6.12%378.88M | 17.66%783.1M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | 455.42%156.94M | 100.92%49.13M | --28.26M | --24.45M |
| Earning after tax | -35.44%239.39M | -41.40%533.47M | -7.41%370.79M | 1.41%910.35M | -15.69%400.46M | -0.59%897.68M | 16.67%475M | 11.83%903.05M | 14.03%407.13M | 21.33%807.55M |
| Minority profit | -35.20%7.14M | -55.84%16.56M | 90.37%11.01M | 160.99%37.5M | 163.59%5.78M | -249.45%-61.48M | -216.05%-9.1M | -183.71%-17.59M | -384.95%-2.88M | 180.56%21.02M |
| Profit attributable to shareholders | -35.44%232.25M | -40.78%516.91M | -8.84%359.77M | -9.00%872.85M | -18.47%394.68M | 4.18%959.16M | 18.07%484.1M | 17.05%920.64M | 15.16%410.01M | 19.52%786.54M |
| Basic earnings per share | -33.33%0.18 | -41.54%0.38 | -6.90%0.27 | -8.45%0.65 | -19.44%0.29 | 4.41%0.71 | 20.00%0.36 | 17.24%0.68 | 15.38%0.3 | 18.37%0.58 |
| Diluted earnings per share | -33.33%0.18 | -41.54%0.38 | -6.90%0.27 | -8.45%0.65 | -19.44%0.29 | 4.41%0.71 | 20.00%0.36 | 17.24%0.68 | 15.38%0.3 | 18.37%0.58 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Dahua International (Hong Kong) Certified Public Accountants Limited | -- | Dahua International (Hong Kong) Certified Public Accountants Limited | -- | Dahua International (Hong Kong) Certified Public Accountants Limited | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.